(Q51857756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Model based analysis of hepatitis B vaccination strategies in the Netherlands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G. Ardine de Wit

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Mirjam Kretzschmar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Marita van de Laar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

30 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1254-1260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Universal hepatitis B vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Universal hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Vaccination against hepatitis B in low endemic countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

The importance of imported infections in maintaining hepatitis B in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

High impact of migration on the prevalence of chronic hepatitis B in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Hepatitis B virus transmission in The Netherlands: a population-based, hierarchical case-control study in a very low-incidence country

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Diversity and origin of hepatitis B virus in Dutch blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

The influence of age on the development of the hepatitis B carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Global epidemiology of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Drug users' participation in a free hepatitis B vaccination program: demographic, behavioral, and social-cognitive determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

The effect of household distribution on transmission and control of highly infectious diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Stochastic multitype epidemics in a community of households: estimation and form of optimal vaccination schemes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

Control of hepatitis B in the United Kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.009

10.1016/J.VACCINE.2008.12.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19118594%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference